Hao Yuan Pharmaceuticals (688131.SH) subsidiary Chongqing Hao Yuan passed the EU QP audit.

"Chinatimes Financial News APP reports that Haoyuan Pharmaceuticals (688131.SH) has announced that recently, the company's controlling subsidiary, Chongqing Haoyuan Biopharmaceutical Co., Ltd. (hereinafter referred to as "Chongqing Haoyuan"), has successfully passed the audit by the European Union's Qualified Person (QP) and officially obtained a compliance audit report issued by the QP."